Total Payments
$42,059
2024 Payments
$4,214
Companies
60
Transactions
1,207
Medicare Patients
580
Medicare Billing
$106,025
Payment Breakdown by Category
Food & Beverage$22,465 (53.4%)
Research$17,248 (41.0%)
Other$1,200 (2.9%)
Education$1,098 (2.6%)
Travel$47.28 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,465 | 1,173 | 53.4% |
| Unspecified | $17,248 | 15 | 41.0% |
| Honoraria | $1,200 | 1 | 2.9% |
| Education | $1,098 | 17 | 2.6% |
| Travel and Lodging | $47.28 | 1 | 0.1% |
Payments by Type
General
$24,810
1,192 transactions
Research
$17,248
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | $14,935 | 47 | $0 (2024) |
| Eli Lilly and Company | $3,452 | 12 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $2,526 | 139 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,282 | 119 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,670 | 90 | $0 (2024) |
| PBG PUERTO RICO LLC | $1,541 | 81 | $0 (2024) |
| ABBVIE INC. | $1,454 | 69 | $0 (2024) |
| Seattle Genetics, Inc. | $1,298 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $1,283 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,034 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,214 | 205 | PBG PUERTO RICO LLC ($435.21) |
| 2023 | $3,825 | 181 | PBG PUERTO RICO LLC ($334.78) |
| 2022 | $3,639 | 179 | PBG PUERTO RICO LLC ($399.44) |
| 2021 | $2,963 | 147 | Janssen Pharmaceuticals, Inc ($439.84) |
| 2020 | $1,955 | 53 | Eli Lilly Export S.A. Puerto Rico Branch ($901.18) |
| 2019 | $3,422 | 137 | Eli Lilly and Company ($761.57) |
| 2018 | $17,990 | 157 | Eli Lilly Export S.A. Puerto Rico Branch ($13,253) |
| 2017 | $4,052 | 148 | Seattle Genetics, Inc. ($1,278) |
All Payment Transactions
1,207 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: BioOncology | ||||||
| 12/17/2024 | Janssen Pharmaceuticals, Inc | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Janssen Pharmaceuticals, Inc | ERLEADA (Drug), RYBREVANT, AKEEGA | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Oncology | ||||||
| 12/16/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Kyprolis (Drug), XGEVA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Bayer Puerto Rico Inc. | Nubeqa (Drug), Stivarga, Vitrakvi | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Oncology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Hematology | ||||||
| 12/05/2024 | ABBVIE INC. | EPKINLY (Drug), VENCLEXTA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Incyte Corporation | JAKAFI (Drug), MONJUVI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Hematology/Oncology | ||||||
| 12/03/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | PBG PUERTO RICO LLC | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | PBG PUERTO RICO LLC | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: NONE | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: BioOncology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | PBG PUERTO RICO LLC | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MONARCH 2- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF FULVESTRANT WITH OR WITHOUT ABEMACICLIB, A CDK4 6 INHIBITOR, FOR WOMEN WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER | Eli Lilly Export S.A. Puerto Rico Branch | $11,804 | 1 |
| A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER | Eli Lilly Export S.A. Puerto Rico Branch | $1,992 | 2 |
| A STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE WITH OR WITHOUT ABEMACICLIB (LY2835219) IN PARTICIPANTS WITH PROSTATE CANCER | Eli Lilly and Company | $1,563 | 3 |
| A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER | Eli Lilly and Company | $1,078 | 3 |
| MONARCH 2- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF FULVESTRANT WITH OR WITHOUT ABEMACICLIB, A CDK4 6 INHIBITOR, FOR WOMEN WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER | Eli Lilly and Company | $811.35 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 102 | 235 | $30,676 | $19,733 |
| 2022 | 3 | 158 | 343 | $45,454 | $29,065 |
| 2021 | 4 | 165 | 384 | $52,052 | $33,142 |
| 2020 | 4 | 155 | 560 | $46,279 | $24,086 |
Total Patients
580
Total Services
1,522
Medicare Billing
$106,025
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 167 | $22,176 | $15,255 | 68.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 68 | $8,500 | $4,478 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 197 | $26,004 | $18,578 | 71.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 122 | $15,250 | $7,652 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $4,200 | $2,835 | 67.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 202 | $26,552 | $19,599 | 73.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 145 | $18,125 | $8,554 | 47.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $4,375 | $3,063 | 70.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 12 | $3,000 | $1,926 | 64.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 62 | 192 | $23,904 | $14,747 | 61.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 153 | $18,950 | $7,568 | 39.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $2,625 | $1,669 | 63.6% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2020 | 11 | 200 | $800.00 | $101.45 | 12.7% |
About Dr. Robert Hunter, MD
Dr. Robert Hunter, MD is a Hematology & Oncology healthcare provider based in Bayamon, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588657522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hunter, MD has received a total of $42,059 in payments from pharmaceutical and medical device companies, with $4,214 received in 2024. These payments were reported across 1,207 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($22,465).
As a Medicare-enrolled provider, Hunter has provided services to 580 Medicare beneficiaries, totaling 1,522 services with total Medicare billing of $106,025. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bayamon, PR
- Active Since 08/24/2005
- Last Updated 03/25/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588657522
Products in Payments
- OPDIVO (Biological) $1,288
- Revlimid (Drug) $914.36
- DARZALEX (Biological) $887.13
- IMBRUVICA (Drug) $768.75
- KEYTRUDA (Biological) $763.84
- IBRANCE (Drug) $737.25
- KISQALI (Drug) $715.04
- VENCLEXTA (Drug) $708.55
- CYRAMZA (Drug) $623.01
- XTANDI (Drug) $587.73
- ERLEADA (Drug) $575.22
- NINLARO (Drug) $567.50
- ZEJULA (Drug) $416.73
- VERZENIO (Drug) $403.00
- LUPRON DEPOT (Drug) $341.45
- ELIQUIS (Drug) $312.57
- IMFINZI (Biological) $312.05
- Lenvima (Drug) $307.33
- JEMPERLI (Biological) $306.14
- BOSULIF (Drug) $296.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bayamon
Kenel Fernandes Barbosa, Md, MD
Hematology & Oncology — Payments: $29,363
Hematology & Oncology $29,363
Juan Vazquez, Md, MD
Hematology & Oncology — Payments: $27,002
Hematology & Oncology $27,002
Myrna Andino-Camacho, Md, MD
Hematology & Oncology — Payments: $19,132
Hematology & Oncology $19,132
Carlos Chiesa, M.d, M.D
Hematology & Oncology — Payments: $18,548
Hematology & Oncology $18,548
Elias Sobrino, Md, MD
Hematology & Oncology — Payments: $16,472
Hematology & Oncology $16,472
Madeleine Garcia Soberal, Md, MD
Hematology & Oncology — Payments: $4,312
Hematology & Oncology $4,312